COVID-19 trials registries data warehouse

 Return to trial list

Trial - ChiCTR2100051297


Column Value
Trial registration number ChiCTR2100051297
Full text link
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

First author
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Chuanjun Zhuo

Contact
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

chuanjunzhuotjmh@vip.163.com

Registration date
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2021-09-18

Recruitment status
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Recruiting

Study design
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

nonRCT

Allocation
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Non-randomized

Design
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Single group assignment

Masking
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not reported

Center
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

multi-center

Study aim
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Prevention

Inclusion criteria
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Patients with depression, schizophrenia, bipolar disorder.

Exclusion criteria
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Patients with severe allergic constitution, patients with serious physical disease, neurological disease.

Number of arms
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

1

Funding
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Nankai Unievesitry Affiliated Tianjin Fourth Center Hospital

Inclusion age min
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

18

Inclusion age max
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

60

Countries
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

China

Type of patients
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Healthy volunteers

Severity scale
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

N/A

Total sample size
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

1500

primary outcome
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Adverse events;anti-body of Covid-19 virus;

Notes
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Phase
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Phase 0

Arms
Last imported at : Sept. 24, 2021, 6 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

[{"arm_notes": "", "treatment_id": 1911, "treatment_name": "Covid-19 vaccine", "treatment_type": "Other covid vaccine", "pharmacological_treatment": "Vaccine"}]